3-aminobenzamide has been researched along with Endotoxemia in 8 studies
Endotoxemia: A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this lipopolysaccharide (LPS)-induced endotoxemia model, the effects of 3-aminobenzamide (3-AB), a poly(ADP-ribose) synthetase (PARS) inhibitor, on ileal apoptosis were evaluated by light microscopy and M30 cell death staining." | 3.71 | The role of poly(ADP-ribose) synthetase inhibition in preventing endotoxemia-induced intestinal epithelial apoptosis. ( Atici, S; Buyukafsar, K; Cinel, I; Cinel, L; Oral, U; Polat, A; Tamer, L, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, Z | 1 |
| Li, L | 1 |
| Chen, L | 1 |
| Yuan, W | 1 |
| Dong, L | 1 |
| Zhang, Y | 1 |
| Wu, H | 1 |
| Wang, C | 1 |
| Cinel, I | 3 |
| Buyukafsar, K | 1 |
| Cinel, L | 2 |
| Polat, A | 1 |
| Atici, S | 1 |
| Tamer, L | 2 |
| Oral, U | 1 |
| Dirlik, M | 1 |
| Caglikulekci, M | 1 |
| Pata, C | 1 |
| Kanik, A | 1 |
| Ocal, K | 1 |
| Ogetman, Z | 1 |
| Aydin, S | 1 |
| Kiefmann, R | 1 |
| Heckel, K | 1 |
| Schenkat, S | 1 |
| Dörger, M | 1 |
| Wesierska-Gadek, J | 1 |
| Goetz, AE | 1 |
| Wray, GM | 1 |
| Hinds, CJ | 1 |
| Thiemermann, C | 1 |
| Pulido, EJ | 1 |
| Shames, BD | 1 |
| Selzman, CH | 1 |
| Barton, HA | 1 |
| Banerjee, A | 1 |
| Bensard, DD | 1 |
| McIntyre, RC | 1 |
| Anderson, JL | 1 |
| Williams, G | 1 |
| Head, SI | 1 |
| Taner, AS | 1 |
| Ozer, L | 1 |
| Onde, U | 1 |
| Taner, D | 1 |
| Koksoy, C | 1 |
8 other studies available for 3-aminobenzamide and Endotoxemia
| Article | Year |
|---|---|
PARP-1 mediates LPS-induced HMGB1 release by macrophages through regulation of HMGB1 acetylation.
Topics: Acetylation; Acetylcysteine; Animals; Benzamides; Cell Nucleus; Cytoplasm; Disease Models, Animal; E | 2014 |
The role of poly(ADP-ribose) synthetase inhibition in preventing endotoxemia-induced intestinal epithelial apoptosis.
Topics: Animals; Apoptosis; Benzamides; Endotoxemia; Epithelium; Escherichia coli Infections; Immunohistoche | 2002 |
The effect of PARS inhibition on ileal histopathology, apoptosis and lipid peroxidation in LPS-induced obstructive jaundice.
Topics: Adenosine Triphosphatases; Analysis of Variance; Animals; Apoptosis; Benzamides; Disease Models, Ani | 2003 |
Platelet-endothelial cell interaction in pulmonary micro-circulation: the role of PARS.
Topics: Animals; Benzamides; Blood Platelets; Cell Communication; Endothelium, Vascular; Endotoxemia; Inflam | 2004 |
Effects of inhibitors of poly(ADP-ribose) synthetase activity on hypotension and multiple organ dysfunction caused by endotoxin.
Topics: Animals; Benzamides; Endotoxemia; Enzyme Inhibitors; Hemodynamics; Hypotension; Isoquinolines; Kidne | 1998 |
Inhibition of PARS attenuates endotoxin-induced dysfunction of pulmonary vasorelaxation.
Topics: Adenosine Triphosphate; Animals; Benzamides; Cyclic GMP; Endotoxemia; Endotoxins; Enzyme Inhibitors; | 1999 |
The role of nitric oxide in diaphragmatic dysfunction in endotoxemic rats.
Topics: Adenosine Triphosphate; Animals; Benzamides; Diaphragm; Endotoxemia; Enzyme Inhibitors; Free Radical | 2001 |
Poly(adp-ribose) synthetase inhibition reduces bacterial translocation in rats after endotoxin challenge.
Topics: Animals; Bacterial Translocation; Benzamides; Colony-Forming Units Assay; Disease Models, Animal; En | 2001 |